Aquilo Partners - Overview

Aquilo Partners is a leading life science investment bank that specializes in mergers & acquisitions, licensing/partnership transactions, and private placements. Our dedicated team of senior bankers is committed to a transparent and thoughtful approach to achieving success in every transaction we undertake.

With our extensive collective experience in life science banking, we have advised on more than $15 billion in M&A and partnering transactions, as well as raised over $8 billion in capital. Our strong relationships with top-tier players in the global life science industry enable us to provide exceptional services to clients in various sectors, including biotechnology, big pharma, specialty pharma, medical devices, research tools, and diagnostics.

At Aquilo Partners, we understand the unique challenges and opportunities within the life science industry. Our expertise and deep industry knowledge allow us to offer strategic guidance and tailored solutions to our clients. Whether it’s facilitating mergers and acquisitions, structuring licensing and partnership transactions, or assisting with private placements, we are dedicated to delivering exceptional results.

We believe in the power of collaboration and building long-term relationships with our clients. By working closely with them, we gain a comprehensive understanding of their goals and objectives, enabling us to provide personalized and effective solutions. Our commitment to excellence, integrity, and client satisfaction sets us apart as a trusted partner in the life science investment banking sector.

In summary, Aquilo Partners is a highly reputable life science investment bank that offers a wide range of services, including mergers & acquisitions, licensing/partnership transactions, and private placements. With our experienced team and strong industry relationships, we are well-equipped to provide strategic guidance and deliver successful outcomes for our clients in the ever-evolving life science landscape.